Search all medical codes

Injection, infliximab-abda, biosimilar, (renflexis), 10 mg

HCPCS code

Name of the Procedure:

Injection, infliximab-abda, biosimilar, (Renflexis), 10 mg (Q5104)

Summary

This procedure involves administering the biosimilar drug infliximab-abda (Renflexis) via injection. It's a treatment commonly used to reduce inflammation and manage symptoms associated with various autoimmune conditions.

Purpose

Medical Conditions Addressed:

  • Rheumatoid arthritis
  • Crohn's disease
  • Ulcerative colitis
  • Ankylosing spondylitis
  • Psoriatic arthritis
  • Plaque psoriasis

Goals/Expected Outcomes: To relieve inflammation, reduce pain and swelling, improve joint function, and help manage overall symptoms of autoimmune diseases.

Indications

Conditions Warranting the Procedure:

  • Severe and active autoimmune disease symptoms not adequately managed by other treatments.
  • Patients experiencing flare-ups or worsening of their condition.

Patient Criteria:

  • Diagnosis of a qualifying autoimmune disorder.
  • Unresponsive or intolerant to conventional therapy.
  • Assessment by a healthcare provider confirming the necessity for infliximab-abda treatment.

Preparation

Pre-Procedure Instructions:

  • Discuss medical history and current medications with your healthcare provider.
  • Undergo any necessary blood tests or screenings.
  • Inform the doctor about any signs of infection or recent vaccinations.
  • No specific fasting required, but follow specific instructions from the healthcare provider.

Procedure Description

  1. Initial Assessment: Medical history and vital signs are reviewed.
  2. Injection Preparation: The healthcare provider prepares the precise dosage of infliximab-abda (Renflexis), 10 mg.
  3. Administration: The drug is injected intravenously (IV) or as prescribed by the healthcare provider, typically over a period of 2 hours.
  4. Monitoring: The patient is monitored for any adverse reactions during and after the injection.

Tools and Equipment:

  • Sterile needles and syringes
  • IV infusion setup (if applicable)

Anesthesia/Sedation:

  • Not typically required, but comfort measures may be provided.

Duration

The administration usually takes about 2 hours, but the total time at the clinic may be longer depending on observation requirements post-injection.

Setting

The procedure is usually performed in:

  • Outpatient clinic
  • Hospital infusion center

Personnel

Involved Healthcare Professionals:

  • Nurse or trained healthcare provider for administration
  • Possibly a physician or specialist overseeing the procedure

Risks and Complications

Common Risks:

  • Injection site reactions (pain, redness, swelling)

Rare Risks:

  • Allergic reactions
  • Infections due to immune suppression
  • Liver dysfunction
  • Heart problems

Management of Complications:

  • Immediate medical attention if severe reactions occur.
  • Pre-treatment assessments to mitigate risks.

Benefits

Expected Benefits:

  • Reduction in autoimmune disease activity
  • Improved quality of life
  • Symptom management within a few days to weeks

Recovery

Post-Procedure Care:

  • Monitoring for immediate adverse reactions
  • Routine follow-up appointments as needed

Recovery Time:

  • Minimal downtime; normal activities can usually resume shortly after monitoring.

Restrictions:

  • Avoid activities that might increase the risk of infection.
  • Follow specific instructions from your healthcare provider.

Alternatives

Other Treatment Options:

  • Other biologics (e.g., adalimumab, etanercept)
  • Conventional therapy (e.g., methotrexate, corticosteroids)

Comparative Pros and Cons:

  • Alternative biologics may offer similar benefits with different side effect profiles.
  • Conventional therapies may be less expensive but might not be as effective for severe cases.

Patient Experience

During the Procedure:

  • Some discomfort at the injection site.
  • Possible mild side effects like headache, nausea, or fatigue.

After the Procedure:

  • Most patients feel well enough to resume their daily activities after observation.
  • Pain management and supportive care are provided as needed.

Always consult with your healthcare provider for personalized medical advice tailored to your specific condition and treatment needs.

Medical Policies and Guidelines for Injection, infliximab-abda, biosimilar, (renflexis), 10 mg

Related policies from health plans

Similar Codes



Contact us to learn more

Choose your own adventure

Email

Send us a message or questions and we can share more details.

Meet

Setup a calendar meeting with us; find a time now.